FindTrial
Sign In

Clinical application of MRI enhanced post-processing technique in evaluation of tumor activity after thermal ablation of liver cancer

Clinical application of MRI enhanced post-processing technique in evaluation of tumor activity after thermal ablation of liver cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900026589
Enrollment
Unknown
Registered
2019-10-15
Start date
2018-04-01
Completion date
Unknown
Last updated
2019-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver cancer

Interventions

Gold Standard:dynamic phase subtraction, DPS
Index test:Without&#32
dynamic&#32
phase&#32
subtraction,&#32
DPS

Sponsors

Hospital of Chengdu office of People's Goverment of Tibetan Autonomous Region
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Sixty patients with liver cancer who underwent PMCT (alone or in combination with TACE) were followed up for at least 1 month.

Exclusion criteria

Exclusion criteria: 1. Loss of liver cancer after PMCT; 2. With MRI check contraindications; 3. Patients with poor coordination and poor image quality.

Design outcomes

Primary

MeasureTime frame
the lesion enhanced or not;Kappa value;SEN, SPE, ACC, AUC of ROC;—

Countries

China

Contacts

Public ContactYi Zhou

Hospital of Chengdu office of People's Goverment of Tibetan Autonomous Region

595356700@qq.com+86 13880918119

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026